Biblioteca Virtuale per la Salute – Piemonte – "Le biblioteche non si fanno…crescono" A. Birrell

Sfoglia per RIVISTA
TRANSLATIONAL LUNG CANCER RESEARCH
Collezione AOU San Luigi di Orbassano

Items : 22

Association between changes in thioredoxin reductase and other peripheral blood biomarkers with response to PD-1 inhibitor-based combination immunotherapy in non-small cell lung cancer: a retrospective study. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):757-775. doi: 10.21037/tlcr-22-300.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Shen B; Wang X; Bironzo P; Spitaleri G; Hofman P; Peng W; Zhu M; Wang R; Xia J; Chen Y; Du X; Wen S;

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review. in Translational lung cancer research / Transl Lung Cancer Res. 2022 May;11(5):935-949. doi: 10.21037/tlcr-22-1.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Garbo E; Listì A; Bertaglia V; Bironzo P; Passiglia F; Scagliotti GV;

Rate and risk factors of recurrent immune checkpoint inhibitor-related pneumonitis in patients with lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Mar;11(3):381-392. doi: 10.21037/tlcr-22-168.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Passiglia F; Leong TL; Facchinetti F; Liu B; Wang L; Liu Q; Ji S; Wu D; Li F; Tao H; Hu Y;

Expert consensus on perioperative treatment for non-small cell lung cancer. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jul;11(7):1247-1267. doi: 10.21037/tlcr-22-527.

2022
ASL Torino 4
AOU San Luigi di Orbassano

Sakanoue I; Rodriguez M; Owen DH; Novoa NM; Minervini F; Metro G; Lin SH; Kim JJ; John T; Gridelli C; Gobbini E; Brunelli A; Fiorelli A; Bongiolatti S; Zhou Q; Zhou Q; Zhou C; Ying J; Yang N; Yao Y; Wang Q; Yang F; Wang J; Shi M; Lu Y; Long H; Jiang T; Huang Y; Hu J; et alii...

Smoking burden, MPOWER, future tobacco control and real-world challenges in China: reflections on the WHO report on the global tobacco epidemic 2021. in Translational lung cancer research / Transl Lung Cancer Res. 2022 Jan;11(1):117-121. doi: 10.21037/tlcr-22-27.

2022
AOU San Luigi di Orbassano

Zhang J; Roviello G; Novello S; Mariniello A; Pérez-Ríos M; Zhang K; Tartarone A;

Expert consensus on resection of chest wall tumors and chest wall reconstruction. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Nov;10(11):4057-4083. doi: 10.21037/tlcr-21-935.

2021
AOU San Luigi di Orbassano

Wang L; Yan X; Zhao J; Chen C; Chen C; Chen J; Chen KN; Cao T; Chen MW; Duan H; Fan J; Fu J; Gao S; Guo H; Guo S; Guo W; Han Y; Jiang GN; Jiang H; Jiao WJ; Kang M; Leng X; Li HC; Li J; Li J; Li SM; Li S; Li Z; Li Z; et alii...

Exploring the immune-checkpoint inhibitors' efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jun;10(6):2876-2889. doi: 10.21037/tlcr-20-635.

2021
AOU San Luigi di Orbassano

Passiglia F; Cetoretta V; De Filippis M; Napoli V; Novello S;

Local for advanced, is this a paradox? in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3324-3328. doi: 10.21037/tlcr-20-771.

2021
AOU San Luigi di Orbassano

Bungaro M; Paratore C; Bironzo P; Novello S;

Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3191-3202. doi: 10.21037/tlcr-21-455.

2021
AOU San Luigi di Orbassano

Zhang X; Tian D; Chen Y; Chen C; He LN; Zhou Y; Li H; Lin Z; Chen T; Wang Y; Russo A; Nadal E; Passiglia F; Soo RA; Watanabe S; Moran T; Oh IJ; Fu S; Hong S; Zhang L;

Is there any place for PD-1/CTLA-4 inhibitors combination in the first-line treatment of advanced NSCLC?-a trial-level meta-analysis in PD-L1 selected subgroups. in Translational lung cancer research / Transl Lung Cancer Res. 2021 Jul;10(7):3106-3119. doi: 10.21037/tlcr-21-52.

2021
AOU San Luigi di Orbassano

Passiglia F; Galvano A; Gristina V; Barraco N; Castiglia M; Perez A; La Mantia M; Russo A; Bazan V;

Adjuvant epidermal growth factor receptor tyrosine kinase inhibitors: are we actually ready? in Translational lung cancer research / Transl Lung Cancer Res. 2020 Oct;9(5):1724-1727. doi: 10.21037/tlcr-20-545.